All News about Pfizer
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
October 14, 2024
Via Benzinga
Exposures
Product Safety
(PFE) - Analyzing Pfizer's Short Interest
October 11, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|